News for Surface Oncology, Inc. (SURF)

”“ Strategic transformation to innovative oncology completed in Q2 2025 ”“ ”“ Positive CHS-114 (anti-CCR8 antibody) Phase 1b dose expansion study data in pa

”“ Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures ”“”“ UDENYCA® net revenue increased 62% year-over-year ”“”“

**media[562476]**

HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

Earnings call: Coherus BioSciences reports growth and pipeline progress

– Net revenue of $77.1 million in Q1 2024 –  – CRI and ENB Therapeutics development partnership for toripalimab in ovarian cancer – – New debt...

– Launch of LOQTORZI offers first and only FDA-approved treatment for NPC in all lines of therapy – – Indicated in combination with chemotherapy for...

– Net revenue rose 27% from prior quarter to $74.6 million –– CIMERLI® net sales increased 50% to $40 million compared to prior quarter –– LOQTORZI™ now...

– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in vitro, supporting ongoing clinical development of...

–  LOQTORZI is the first and only FDA-approved treatment for NPC – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy...

— Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and enhanced clinical efficacy irrespective of PD-L1 status...

– Resubmission follows the satisfactory resolution of the FDA’s review of inspection findings at the third-party filler – REDWOOD CITY, Calif., Oct. 05,...

REDWOOD CITY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today announced the presentation of three...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York...

Cathie Wood has four decades of investment experience in the finance industry. Her focus as a portfolio manager is solely on publicly traded companies with

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new ...

Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ:AAPL) stake in the ARK Fintech Innovation ETF (NYSE:ARKF) on Thursda...

Surface Oncology, Inc. (SURF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.